Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 51 - 75 of 1049 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Ethinylestradiol	Approved	IGFBP4	3487	increased	Ethinyl Estradiol results in increased expression of IGFBP4 protein	17q21.2	A26384
Testosterone	Approved Investigational	IGFBP2	3485	increased	Testosterone results in increased expression of IGFBP2 protein	2q35	A26384
Testosterone	Approved Investigational	IGFBP6	3489	increased	Testosterone results in increased expression of IGFBP6 protein	12q13.13	A26384
Testosterone	Approved Investigational	IGF1	3479	increased	Testosterone results in increased expression of IGF1 protein	12q23.2	A26385
Testosterone	Approved Investigational	TFRC	7037	increased	Testosterone results in increased expression of TFRC protein	3q29	A26385
Pioglitazone	Approved Investigational	APOB	338	decreased	pioglitazone results in decreased expression of APOB protein	2p24.1	A26386
Iloprost	Approved Investigational	IL1B	3553	decreased	Iloprost results in decreased expression of IL1B protein	2q14.1	A26387
Iloprost	Approved Investigational	IL6	3569	decreased	Iloprost results in decreased expression of IL6 protein	7p15.3	A26387
Iloprost	Approved Investigational	SELL	6402	decreased	Iloprost results in decreased expression of SELL protein	1q24.2	A26387
Candesartan cilexetil	Approved	CD40LG	959	decreased	candesartan results in decreased expression of CD40LG protein	Xq26.3	A26388
Fenofibrate	Approved	CD40LG	959	decreased	Fenofibrate results in decreased expression of CD40LG protein	Xq26.3	A26388
Candesartan cilexetil	Approved	ADIPOQ	9370	increased	candesartan results in increased expression of ADIPOQ protein	3q27.3	A26388
Fenofibrate	Approved	ADIPOQ	9370	increased	Fenofibrate results in increased expression of ADIPOQ protein	3q27.3	A26388
Folic acid	Approved Nutraceutical Vet Approved	CCL2	6347	decreased	Folic Acid results in decreased expression of CCL2 protein	17q12	A26389
Folic acid	Approved Nutraceutical Vet Approved	CRP	1401	decreased	Folic Acid results in decreased expression of CRP protein	1q23.2	A26389
Folic acid	Approved Nutraceutical Vet Approved	CXCL8	3576	decreased	Folic Acid results in decreased expression of CXCL8 protein	4q13.3	A26389
Bumetanide	Approved	REN	5972	increased	Bumetanide results in increased expression of REN protein	1q32.1	A26390
Trandolapril	Approved	REN	5972	increased	trandolapril results in increased expression of REN protein	1q32.1	A26390
Docetaxel	Approved Investigational	KRT18	3875	increased	docetaxel results in increased expression of KRT18 protein	12q13.13	A26391
Estramustine	Approved Investigational	KRT18	3875	increased	Estramustine results in increased expression of KRT18 protein	12q13.13	A26391
Vinorelbine	Approved Investigational	KRT18	3875	increased	vinorelbine results in increased expression of KRT18 protein	12q13.13	A26391
Bicalutamide	Approved	IGF1	3479	increased	bicalutamide results in increased expression of IGF1 protein	12q23.2	A26392
Bicalutamide	Approved	IGFBP3	3486	increased	bicalutamide results in increased expression of IGFBP3 protein	7p12.3	A26392
Formaldehyde	Approved Vet Approved	AFP	174	increased	Formaldehyde results in increased expression of AFP protein	4q13.3	A26393
Phenol	Approved Experimental	AFP	174	increased	Phenol results in increased expression of AFP protein	4q13.3	A26393

Displaying entries 51 - 75 of 1049 in total

Pharmaco-proteomicsSerum protein concentration changes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability